BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 81 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $57 | 0.0% | 2,575 | 0.0% | 0.00% | – |
Q2 2023 | $57 | +1.8% | 2,575 | 0.0% | 0.00% | – |
Q1 2023 | $56 | -5.1% | 2,575 | 0.0% | 0.00% | – |
Q4 2022 | $59 | -99.9% | 2,575 | 0.0% | 0.00% | – |
Q3 2022 | $59,000 | +63.9% | 2,575 | 0.0% | 0.00% | – |
Q2 2022 | $36,000 | -23.4% | 2,575 | +134.1% | 0.00% | – |
Q3 2021 | $47,000 | -52.0% | 1,100 | -50.0% | 0.00% | – |
Q2 2021 | $98,000 | +22.5% | 2,200 | 0.0% | 0.00% | – |
Q1 2021 | $80,000 | -83.4% | 2,200 | 0.0% | 0.00% | – |
Q4 2020 | $483,000 | +654.7% | 2,200 | 0.0% | 0.00% | – |
Q3 2020 | $64,000 | +77.8% | 2,200 | 0.0% | 0.00% | – |
Q2 2020 | $36,000 | +260.0% | 2,200 | +100.0% | 0.00% | – |
Q1 2020 | $10,000 | -44.4% | 1,100 | 0.0% | 0.00% | – |
Q4 2019 | $18,000 | -58.1% | 1,100 | -57.4% | 0.00% | – |
Q3 2019 | $43,000 | +115.0% | 2,580 | +134.5% | 0.00% | – |
Q2 2019 | $20,000 | 0.0% | 1,100 | 0.0% | 0.00% | – |
Q1 2019 | $20,000 | +53.8% | 1,100 | 0.0% | 0.00% | – |
Q4 2018 | $13,000 | – | 1,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |